News
BWAY
22.99
+1.32%
0.30
Brainsway management to meet virtually with Northland
TipRanks · 3d ago
Weekly Report: what happened at BWAY last week (0202-0206)?
Weekly Report · 5d ago
Weekly Report: what happened at BWAY last week (0126-0130)?
Weekly Report · 02/02 09:32
Are Biotech And Pharma Stocks Poised To Keep Climbing After Hitting 52-Week Highs?
NASDAQ · 01/27 10:34
Meta To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga · 01/26 13:35
Brainsway Price Target Raised to $30.00/Share From $24.00 by HC Wainwright & Co.
Dow Jones · 01/26 12:03
Brainsway Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 01/26 12:03
What Analysts Are Saying About BrainsWay Stock
Benzinga · 01/26 12:00
HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $30
Benzinga · 01/26 11:54
Analysts Are Bullish on Top Healthcare Stocks: ImmunityBio (IBRX), Brainsway (BWAY)
TipRanks · 01/26 11:20
Brainsway price target raised to $30 from $24 at H.C. Wainwright
TipRanks · 01/26 11:11
Weekly Report: what happened at BWAY last week (0119-0123)?
Weekly Report · 01/26 09:32
Brainsway price target raised to $30 from $23 at Northland
TipRanks · 01/22 14:06
BrainsWay Wins Draft Highmark Coverage for Accelerated Deep TMS Depression Protocol
TipRanks · 01/21 12:58
BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™
Barchart · 01/21 06:30
Weekly Report: what happened at BWAY last week (0112-0116)?
Weekly Report · 01/19 09:35
BrainsWay Highlights FDA Approval of Neurolief’s At-Home Proliv Rx Device for Treatment-Resistant Depression
TipRanks · 01/12 12:57
Brainsway announces U.S. FDA granted PMA for Neurolief’s ProlivRx system
TipRanks · 01/12 12:47
The FDA Grants Premarket Approval For BrainsWay's BrainsWay's Neurolief's Proliv Rx System As An Adjunctive Treatment For Major Depressive Disorder In Patients Who Did Not Benefit From Previous Antidepressant Medication
Benzinga · 01/12 12:36
FDA Approves Neurolief’s ProlivRx System for At-Home Treatment of Major Depressive Disorder
Reuters · 01/12 12:30
More
Webull provides a variety of real-time BWAY stock news. You can receive the latest news about Brainsway Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About BWAY
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.